Teleflex to Present at the BofA Securities 2025 Health Care Conference
The FDA Has Granted 510(k) Clearance Of An Expansion To The Indications For Use Of Teleflex's QuikClot Control+ Hemostatic Device To Include All Grades Of Internal And External Bleeding
Teleflex Receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+ Hemostatic Device
Express News | Teleflex Receives FDA 510(K) Clearance for Expanded Indications of the Quikclot Control+™ Hemostatic Device
Earnings Preview: Teleflex to Report Financial Results Pre-market on May 01
Teleflex Announces Clinical and Real-World Evidence Studies and Physician Educational Opportunities to Be Highlighted at the 2025 American Urological Association (AUA) Annual Meeting
There Is A Reason Teleflex Incorporated's (NYSE:TFX) Price Is Undemanding
Teleflex Incorporated to Host Conference Call for Q1 Financial Results on May 1, 2025
Mizuho Securities Maintains Teleflex(TFX.US) With Hold Rating, Cuts Target Price to $155
Teleflex Price Target Lowered to $155 From $175 at Mizuho
RBC Capital Upgrades Teleflex(TFX.US) to Buy Rating, Cuts Target Price to $150
Truist Financial Maintains Teleflex(TFX.US) With Hold Rating, Cuts Target Price to $140
Truist Cuts Price Target on Teleflex to $140 From $149, Keeps Hold Rating
Pharma, MedTech Stocks Bounce Back as Trump Pauses Most Tariffs
Teleflex (NYSE:TFX) Sheds US$272m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Three Years
Is the Market Bullish or Bearish on Teleflex?
5 Analysts Assess Teleflex: What You Need To Know
Express News | Citizens Capital Markets Reiterates Market Perform on Teleflexto Market Perform
Teleflex Analyst Ratings
JMP Securities Maintains Teleflex(TFX.US) With Hold Rating